US2017245891A1PendingUtilityA1

Methods and systems for controlled deployment of needles in tissue

63
Assignee: GYNESONICS INCPriority: Oct 12, 2007Filed: May 17, 2017Published: Aug 31, 2017
Est. expiryOct 12, 2027(~1.2 yrs left)· nominal 20-yr term from priority
A61B 10/0045A61B 2010/045A61B 18/1477A61B 2034/107A61B 90/11A61M 5/46A61B 2018/1425A61B 90/36A61B 2090/378A61B 17/42A61B 34/10A61B 8/0841A61B 8/12
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.

Claims

exact text as granted — not AI-modified
1 . A method for facilitating treatment of uterine anatomy, the method comprising:
 positioning a probe proximate to the uterine anatomy;   using the probe to provide an image of the uterine anatomy;   overlaying the image with projected treatment region and a safety boundary based on an estimated or actual position of a tissue treatment device, wherein the projected treatment region includes at least a portion of uterine anatomy to be treated; and   aligning the projected treatment region on the image so that the projected treatment region includes at least a portion of the uterine anatomy to be treated and so that a sensitive anatomical structure is outside of the safety boundary.   
     
     
         2 . The method of  claim 1 , wherein aligning the projected treatment region comprises positioning the tissue treatment device to align with the projected treatment region. 
     
     
         3 . The method of  claim 1 , further comprising overlaying the image with a projected position of the tissue treatment device. 
     
     
         4 . The method of  claim 1 , wherein the tissue treatment device comprises a deployable needle configured to ablate the uterine anatomy. 
     
     
         5 . The method of  claim 1 , wherein the probe comprises the tissue treatment device. 
     
     
         6 . The method of  claim 5 , wherein the tissue treatment device comprises a RF ablation needle. 
     
     
         7 . The method of  claim 1 , wherein the probe is delivered transvaginally into a uterus of a subject comprising the uterine anatomy. 
     
     
         8 . The method of  claim 1 , wherein using the probe to provide the image of the uterine anatomy comprises using the probe to provide a real time image of a uterine fibroid to be treated, wherein the sensitive anatomical structure comprises serosa, and wherein the projected treatment region includes at least a portion of a uterine fibroid to be treated. 
     
     
         9 . A method for facilitating treatment of uterine anatomy, the method comprising:
 positioning a probe proximate to the uterine anatomy;   using the probe to provide an image of the uterine anatomy;   overlaying the image with a projected treatment region based on an estimated or actual position of a tissue treatment device, wherein the projected treatment region includes at least a portion of uterine anatomy to be treated; and   aligning the projected treatment region on the image so that the projected treatment region includes at least a portion of the uterine anatomy to be treated.   
     
     
         10 . The method of  claim 9 , wherein aligning the projected treatment region comprises positioning the tissue treatment device to align with the projected treatment region. 
     
     
         11 . The method of  claim 9 , further comprising overlaying the image with a projected position of the tissue treatment device. 
     
     
         12 . The method of  claim 9 , wherein the probe is used to provide an image of a uterine fibroid to be treated, and the projected treatment region includes at least a portion of a uterine fibroid to be treated. 
     
     
         13 . The method of  claim 9 , wherein the tissue treatment device comprises a deployable needle configured to ablate uterine anatomy. 
     
     
         14 . The method of  claim 9 , wherein the tissue treatment device is included on the probe. 
     
     
         15 . The method of  claim 9 , wherein the probe is delivered transvaginally into a uterus of a subject comprising the uterine anatomy. 
     
     
         16 . A method for facilitating treatment of uterine anatomy, the method comprising:
 positioning a probe proximate to the uterine anatomy;   using the probe to provide an image of the uterine anatomy including a sensitive anatomical structure;   overlaying the image with a safety boundary based on an estimated or actual position of a tissue treatment device; and   adjusting the safety boundary on the image so that the sensitive anatomical structure is outside of the safety boundary.   
     
     
         17 . The method of  claim 16 , wherein the probe comprises the tissue treatment device. 
     
     
         18 . The method of  claim 16 , wherein the tissue treatment device comprises an array of RF ablation needles. 
     
     
         19 . The method of  claim 16 , wherein the tissue treatment device comprises a deployable needle configured to ablate the uterine anatomy. 
     
     
         20 . The method of  claim 19 , wherein the safety boundary is based on a position of the deployable needle prior to the needle being deployed. 
     
     
         21 . The method of  claim 19 , wherein the safety boundary is based on a position of the deployable needle after the needle is deployed. 
     
     
         22 . The method of  claim 16 , wherein adjusting the safety boundary on the image comprises positioning the tissue treatment device to adjust the safety boundary. 
     
     
         23 . The method of  claim 16 , further comprising overlaying the image with a projected position of a tissue treatment device. 
     
     
         24 . The method of  claim 16 , wherein the sensitive anatomical structure comprises serosa. 
     
     
         25 . The method of  claim 16 , wherein the uterine anatomy comprises a uterine fibroid. 
     
     
         26 . The method of  claim 16 , wherein the safety boundary comprises an oval line. 
     
     
         27 . The method of  claim 16 , wherein the safety boundary is between 1 cm and 3 cm outward of a projected treatment region boundary. 
     
     
         28 . The method of  claim 16 , wherein the probe is delivered transvaginally into a uterus of a subject comprising the uterine anatomy. 
     
     
         29 . The method of  claim 16 , wherein the probe comprises the tissue treatment device, wherein the tissue treatment device comprises an array of RF ablation needles, wherein the uterine anatomy comprises a uterine fibroid, and wherein the sensitive anatomical structure comprises serosa.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.